# Floraworks Holdings

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/floraworks-holdings

- Industry: Biotechnology
- Headquarters: Milwaukie, US
- Website: www.flora-works.com
- Total disclosed funding: $2.5M
- Latest round: Series A (Jun 21, 2023)
- Investors on record: 2

## About

Based in Oregon, US, and founded in 2019, FloraWorks Holdings Inc. operates as a biotechnology company specializing in cannabinoids for medical needs. In December 2022, the firm raised its series A funding led by investor Bonaventure Capital. The company as of December 2022 is led by its CEO, Alan Ridgeway. 

The company offers cannabinoid isolation through proprietary refinement methods, specialized formulation, and product development for client’s products and therapeutic medicine including cannabinoids as an ingredient, technical expertise in quality assurance, and regulatory guidance for therapeutic medicine.

The company plans to utilize its December 2022 funding to further develop its cannabinoid therapeutics for people.

## Funding rounds

- Series A, Jun 21, 2023, $2.3M — Bonaventure Capital, ArcView Group
- Series A, Dec 13, 2022, $0.3M — Bonaventure Capital

## Investors

- Bonaventure Capital (https://capitalatlas.ai/funds/bonaventure-capital) — Series A
- ArcView Group (https://capitalatlas.ai/funds/arcview-group) — Series A